Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Condition:   Barrett's Esophagus
    Intervention:  
    Sponsor:   Abramson Cancer Center of the University of Pennsylvania
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Device: Sponge capsule
    Sponsors:   Mayo Clinic;   Exact Sciences Corporation
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Drug: KSP/QRH dimer
    Sponsor:   University of Michigan
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:  
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Device: Tethered Capsule Endomicroscopy (TCE)
    Sponsors:   Massachusetts General Hospital;   Columbia University;   Mayo Clinic;   Kansas City Veteran Affairs Medical Center;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Barrett Esophagus
    Interventions:   Procedure: Esophagogastroduodenoscopy with high definition-white light end endoscopy (HD-WLE) and narrow band imaging (NBI);   Device: Olympus Disposable Distal Attachment Cap
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Device: Experimental OFDI Imaging
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Barretts Esophagus With Dysplasia
    Intervention:   Drug: Alginates
    Sponsor:   Medical University of South Carolina
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Device: The Nvision VLE Imaging System
    Sponsors:   Mayo Clinic;   American Society for Gastrointestinal Endoscopy
    Recruiting

  • Conditions:   Barrett's Esophagus;   High-grade Dysplasia in Barrett Esophagus;   Low Grade Dysplasia in Barrett Esophagus
    Interventions:   Device: Hybrid argon plasma ablation (HAPC);   Device: Radiofrequency ablation (RFA)
    Sponsors:   Erbe Elektromedizin GmbH;   Erbe USA Incorporated;   Kansas City Veteran Affairs Medical Center;   Emissary International LLC
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Device: OFDI Capsule Marking
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Adenocarcinoma
    Intervention:   Device: Sponge Capsule
    Sponsor:   Mayo Clinic
    Not yet recruiting

  • Condition:   Barrett Esophagus Adenocarcinoma
    Interventions:   Procedure: Complete endoscopic resection at Day 1 and months 2, 4, 6 8 and month 10.;   Device: Endoscopic resection at month 2 and month 4
    Sponsor:   Institut Paoli-Calmettes
    Recruiting

  • Conditions:   Barrett's Esophagus;   Esophageal Adenocarcinoma
    Intervention:   Other: EMR and RFA effect on stem cell marker expression in BE/EAC
    Sponsor:   University of Oklahoma
    Recruiting

  • Conditions:   Barrett's Esophagus;   Esophageal Cancer
    Interventions:   Procedure: Endoscopic eradication therapies (EET);   Procedure: Esophagectomy;   Drug: Chemotherapy;   Radiation: Radiation
    Sponsors:   University of Colorado, Denver;   Feinberg School of Medicine, Northwestern University;   University of California, Los Angeles;   H. Lee Moffitt Cancer Center and Research Institute;   California Pacific Medical Center
    Recruiting

  • Conditions:   Barrett Esophagus;   Barrett Adenocarcinoma;   Esophagus Neoplasm
    Interventions:   Procedure: Endoscopic mucosal resection;   Procedure: Endoscopic submucosal dissection
    Sponsor:   Universitätsklinikum Hamburg-Eppendorf
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Other: Video intervention
    Sponsor:   Northwestern University
    Recruiting

  • Condition:   Barretts Esophagus
    Intervention:  
    Sponsor:   Professor Michael Bourke
    Not yet recruiting

  • Condition:   Squamous Cell Carcinoma of the Esophagus
    Interventions:   Drug: Ramucirumab;   Drug: Paclitaxel
    Sponsors:   IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest;   Eli Lilly and Company;   Trium Analysis Online GmbH
    Recruiting

  • Condition:   Cancer of Esophagus
    Intervention:  
    Sponsors:   Aarhus University Hospital Skejby;   Danish Cancer Society
    Recruiting

  • Condition:   Esophagus Squamous Cell Carcinoma
    Intervention:   Drug: raltitrexed
    Sponsor:   Huai'an First People's Hospital
    Recruiting

  • Condition:   Barretts Esophagus With Dysplasia
    Interventions:   Device: EndoRotor Mucosal Resection System;   Device: Continued Ablation
    Sponsor:   Interscope, Inc.
    Recruiting

  • Condition:   Barrett's Esophagus With Dysplasia
    Interventions:   Device: Mucosal Impedance;   Other: Research Biopsies;   Device: Volumetric Laser Endomicroscopy
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Barrett's Esophagus;   Radiofrequency Ablation;   Gastroesophageal Reflux Disease
    Intervention:  
    Sponsors:   Matthias Paireder;   Medtronic - MITG
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Neoplasms;   Reflux Esophagitis
    Intervention:   Device: Endoscopy with Polyscope (Polydiagnost TM) coupled with Multi-Spectral Imaging light-source
    Sponsor:   University of Cambridge
    Recruiting

  • Condition:   Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment
    Intervention:   Drug: PDR001+MCS110
    Sponsor:   Yonsei University
    Not yet recruiting

  • Conditions:   Barrett's Esophagus;   Neoplasms;   Gastroesophageal Reflux
    Intervention:  
    Sponsors:   Midwest Biomedical Research Foundation;   Kansas City Veteran Affairs Medical Center
    Recruiting

  • Conditions:   Barrett's Esophagus;   Gastroesophageal Reflux Disease;   Esophageal Adenocarcinoma
    Intervention:  
    Sponsors:   Midwest Biomedical Research Foundation;   Kansas City Veteran Affairs Medical Center
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:  
    Sponsors:   Geisinger Clinic;   Medical University of South Carolina;   Long Island Jewish Medical Center;   Pentax Medical;   Virginia Commonwealth University
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Device: CryoBalloon Ablation System
    Sponsor:   C2 Therapeutics, Inc.
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Other: Biopsies with histopathology
    Sponsor:   Institute for Clinical and Experimental Medicine
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:  
    Sponsor:   Professor Michael Bourke
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Drug: Proflavine, high resolution imaging
    Sponsors:   Anandasabapathy, Sharmila, M.D.;   William Marsh Rice University;   Baylor College of Medicine
    Recruiting

  • Condition:   Barrett Esophagus
    Interventions:   Drug: Bevacizumab-IRDye800CW;   Diagnostic Test: Fluorescence endoscopy
    Sponsors:   University Medical Center Groningen;   Helmholtz Zentrum München
    Not yet recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Procedure: preoperative enhanced chest CT examination
    Sponsor:   Beijing Cancer Hospital
    Recruiting

  • Conditions:   Small Cell Carcinoma of Esophagus;   Advanced Cancer
    Intervention:   Drug: Toripalimab
    Sponsor:   Sun Yat-sen University
    Recruiting

  • Condition:   Esophagus
    Interventions:   Procedure: Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA);   Procedure: Contrast-Enhanced Ultrasound;   Procedure: Fine-Needle Aspiration;   Drug: Sonazoid (Perflubutane)
    Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Cancer
    Intervention:   Diagnostic Test: endoscopy
    Sponsors:   University of Exeter;   University of Bristol;   Gloucestershire Hospitals NHS Foundation Trust
    Not yet recruiting

  • Conditions:   Early Gastric Cancer;   Barrett Esophagus
    Interventions:   Diagnostic Test: Linked Color Imaging;   Diagnostic Test: White Light Imaging
    Sponsors:   Changi General Hospital;   Singapore General Hospital
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Stenosis
    Interventions:   Drug: Prednisolone;   Drug: Placebo Oral Tablet
    Sponsor:   Professor Michael Bourke
    Not yet recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Procedure: Single-hole inflatable mediastinal mirror
    Sponsor:   Qingdong Cao
    Recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Other: Non interventional study
    Sponsors:   Nantes University Hospital;   LLTech
    Recruiting

  • Condition:   Perforation Esophagus
    Intervention:   Device: VACStent
    Sponsor:   University Hospital of Cologne
    Not yet recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Radiation: Proton radiation
    Sponsor:   Loma Linda University
    Recruiting

  • Conditions:   Oesophageal Cancer;   Barrett Esophagus;   Barretts Esophagus With Dysplasia
    Intervention:   Diagnostic Test: Breath test
    Sponsors:   Imperial College London;   Guts UK Charity
    Not yet recruiting

  • Condition:   Eosinophilic Esophagitis
    Intervention:   Device: SECM Capsule
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting

  • Condition:   Eosinophillic Esophagitis
    Intervention:   Device: SECM capsule
    Sponsor:   Massachusetts General Hospital
    Not yet recruiting

  • Condition:   Intubation Complication
    Intervention:   Other: Maneuvers for occluding esophagus
    Sponsor:   SMG-SNU Boramae Medical Center
    Not yet recruiting

  • Conditions:   Lung Cancer;   Esophageal Cancer;   Mesothelioma;   Gastrointestinal Neoplasms;   Breast Cancer
    Intervention:   Drug: Mithramycin
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Optical Enhancement Endoscopy
    Interventions:   Device: first OE;   Device: first WLI
    Sponsor:   Shandong University
    Recruiting

  • Condition:   Non-Small Cell Lung Cancer
    Interventions:   Radiation: Conventional radiotherapy;   Radiation: Esophageal-Sparing Intensity-Modulated Radiotherapy
    Sponsor:   Lawson Health Research Institute
    Recruiting

  • Condition:   Head & Neck Cancer
    Intervention:   Drug: nanoliposomal irinotecan
    Sponsors:   National Health Research Institutes, Taiwan;   China Medical University Hospital;   Tri-Service General Hospital;   Taipei Veterans General Hospital, Taiwan;   National Cheng-Kung University Hospital
    Not yet recruiting

  • Conditions:   Esophageal Adenocarcinoma (UICC TNM7);   Adenocarcinoma of the Esophagogastric Junction
    Interventions:   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Docetaxel;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Neoadjuvant radiation
    Sponsors:   University Hospital Freiburg;   Clinical Trials Unit Freiburg;   CTC laboratories at University of Hamburg and University of Freiburg;   ESOPEC reference pathology at the University of Freiburg;   Universitätsklinikum Leipzig, Universitäres Krebszentrum (UCCL)
    Recruiting

  • Conditions:   Barrett's Esophagus Without Dysplasia;   Barrett's Esophagus With Dysplasia;   Barrett's Esophagus With Low Grade Dysplasia;   Barrett's Esophagus With High Grade Dysplasia;   Barrett's Esophagus With Dysplasia, Unspecified
    Interventions:   Diagnostic Test: IRIS (Intelligent real-time image segmentation);   Diagnostic Test: VLE (Volumetric laser endomicroscopy)
    Sponsors:   Northwell Health;   NinePoint Medical
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Dysplasia;   Esophageal Adenocarcinoma
    Intervention:   Procedure: Diagnostic Test
    Sponsor:   CDx Diagnostics
    Recruiting

  • Conditions:   Esophagus Cancer;   Esophagogastric Junction Cancer
    Interventions:   Device: MRI and CT;   Radiation: Ratiotherapy;   Drug: Paclitaxel, platinum-based drug
    Sponsor:   Chinese Academy of Medical Sciences
    Recruiting

  • Conditions:   Gastric Cancer;   Esophagus Cancer
    Intervention:   Drug: Oxaliplatin+Capecitabine+Pembrolizumab
    Sponsors:   Duke University;   Merck Sharp & Dohme Corp.
    Recruiting

  • Conditions:   Esophagus Adenocarcinoma;   Esophagus Squamous Cell Carcinoma;   Gastroesophageal Junction Adenocarcinoma
    Intervention:   Drug: Itraconazole
    Sponsor:   Dallas VA Medical Center
    Recruiting

  • Conditions:   Cancer of Esophagus;   Cancer, Lung
    Interventions:   Procedure: whole body electromyostimulation exercise;   Procedure: protein-rich nutrition therapy
    Sponsor:   University of Erlangen-Nürnberg Medical School
    Recruiting

  • Conditions:   Esophagus Cancer, Adenocarcinoma;   Stomach Cancer, Adenocarcinoma
    Interventions:   Drug: Rucaparib;   Drug: Ramucirumab;   Drug: Nivolumab
    Sponsors:   Anwaar Saeed;   Bristol-Myers Squibb;   Clovis Oncology, Inc.
    Not yet recruiting

  • Conditions:   Cancer of Stomach;   Cancer of Esophagus
    Intervention:  
    Sponsor:   Parc de Salut Mar
    Recruiting

  • Conditions:   Barrett Esophagus;   Dysplasia;   Esophageal Adenocarcinoma;   Esophageal Squamous Cell Carcinoma;   Gastroesophageal Reflux Disease;   Metaplasia
    Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Device: Swallowable Sponge Cell Sampling Device
    Sponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Esophagus Cancer;   Esophageal Cancer;   Cancer of the Esophagus
    Interventions:   Radiation: Proton beam therapy;   Other: Patient-Reported Outcome Measures
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Conditions:   Barrett Esophagus;   Gastroesophageal Reflux;   Esophageal Dysplasia;   Esophageal Diseases
    Intervention:  
    Sponsors:   CDx Diagnostics;   University of North Carolina, Chapel Hill
    Recruiting

  • Conditions:   Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer;   Cancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma Cancer;   Cancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer
    Intervention:   Other: data collection
    Sponsor:   Abramson Cancer Center of the University of Pennsylvania
    Recruiting

  • Conditions:   Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Gastric Cardia;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIC Esophageal Cancer
    Interventions:   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Case Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Sarcoma;   Rectal Carcinoma;   Esophagus Cancer
    Intervention:   Radiation: Standard treatment
    Sponsor:   Centre Leon Berard
    Recruiting

  • Conditions:   Cancer of Pancreas;   Cancer of Stomach;   Cancer of Esophagus
    Intervention:   Other: Anticipatory care planning letter
    Sponsors:   NHS Lothian;   NHS Fife
    Recruiting

  • Conditions:   Adenocarcinoma of the Oesophagus;   Adenocarcinoma of the Gastro-oesophageal Junction;   Adenocarcinoma of the Stomach
    Interventions:   Drug: Capecitabine;   Drug: MEDI4736;   Drug: Trastuzumab;   Drug: Rucaparib
    Sponsors:   Royal Marsden NHS Foundation Trust;   MedImmune LLC;   Clovis Oncology, Inc.
    Recruiting

  • Condition:   Morbid Obesity
    Intervention:   Diagnostic Test: Gastroscopy
    Sponsor:   University Hospital, Basel, Switzerland
    Recruiting

  • Conditions:   Leakage After Esophagectomy;   Leakage After Gastrectomy;   Perforation of the Esophagus
    Intervention:   Device: Eso-SPONGE® vacuum treatment
    Sponsors:   Aesculap AG;   Universitätsklinikum Kiel
    Recruiting

  • Conditions:   Esophagogastric Cancer;   Moderate to Severe Dysphagia
    Intervention:   Drug: WST 11-mediated VTP therapy
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Weizmann Institute of Science;   Steba Biotech S.A.
    Recruiting

  • Conditions:   Adenocarcinoma of the Gastroesophageal Junction;   Gastric Adenocarcinoma;   Gastric Squamous Cell Carcinoma;   Metastatic Malignant Neoplasm in the Stomach;   Stage IV Esophageal Adenocarcinoma;   Stage IV Esophageal Squamous Cell Carcinoma
    Interventions:   Radiation: External Beam Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
    Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Malignant Pleural Mesotheliomas NOS;   Esophageal Cancers NOS;   Lung Cancer NOS;   Thoracic Cancers;   Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Dysphagia;   Airway Aspiration;   Airway Penetration
    Interventions:   Other: Slower Flow Rate;   Other: Thickened Formula
    Sponsors:   Sudarshan Jadcherla;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Ohio State University;   Medical College of Wisconsin
    Recruiting

  • Conditions:   Barrett Esophagus;   Gastric Antrectomy Partial;   Biliary Duct Stricture;   Pancreatic Duct Stricture;   Colorectal Polyps;   Esophageal Epidermoid Cancer in Pts With Head and Neck Cancer
    Intervention:   Procedure: Confocal endomicroscopy
    Sponsor:   Fauze Maluf Filho
    Recruiting

  • Condition:   Esophageal Cancer
    Interventions:   Procedure: Robotic esophagectomy;   Procedure: Thoracolaparoscopic esophagectomy
    Sponsor:   GEM Hospital & Research Center
    Recruiting

  • Conditions:   Postoperative Complications;   Physical Activity;   Surgery--Complications
    Interventions:   Other: Control;   Other: Exercise - HIIT Intervention
    Sponsors:   University of Dublin, Trinity College;   Health Research Board, Ireland;   Medical Research Charities Group Ireland
    Not yet recruiting

  • Conditions:   Caustic Esophageal Injury;   Esophageal Stenosis;   Pharyngeal Stenosis
    Interventions:   Drug: Methylprednisolone;   Other: Placebo
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting

  • Conditions:   Squamous Carcinoma;   Head and Neck Cancer;   Anal Cancer;   Lung Cancer;   Esophageal Cancer;   Cervix Cancer
    Intervention:  
    Sponsors:   Umeå University;   Lund University
    Recruiting

  • Conditions:   Oesophageal Adenocarcinoma;   Chemotherapy Effect;   Surgery
    Intervention:   Behavioral: Exercise prehabilitation during chemotherapy before surgery
    Sponsor:   Guy's and St Thomas' NHS Foundation Trust
    Recruiting

  • Condition:   Surgical Anastomosis
    Intervention:   Procedure: Hyperspectral Imaging
    Sponsor:   University of Leipzig
    Recruiting

  • Conditions:   Atrial Fibrillation;   Catheter Ablation;   Esophageal Fistula;   Esophageal Diseases;   Arrhythmias, Cardiac
    Intervention:   Device: EnsoETM
    Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
    Recruiting

  • Condition:   Esophageal Neoplasm
    Interventions:   Device: Endodrill Biopsy;   Device: Conventional Biopsy forceps
    Sponsor:   Region Skane
    Recruiting

  • Conditions:   Esophagus Cancer;   Hepatoma;   Glioma;   Gastric Cancer
    Intervention:   Biological: CAR-T/TCR-T cells immunotherapy
    Sponsors:   Shenzhen BinDeBio Ltd.;   Henan Provincial Hospital
    Recruiting

  • Conditions:   Esophagus Cancer;   Esophagogastric Junction Cancer;   Radiotherapy; Complications;   Chemoradiation
    Interventions:   Radiation: SIB-IMRT;   Drug: S-1
    Sponsors:   Chinese Academy of Medical Sciences;   Hebei Medical University Fourth Hospital;   Tianjin Medical University Cancer Institute and Hospital;   Anyang Tumor Hospital;   The First Affiliated Hospital with Nanjing Medical University;   Affiliated Hospital of Hebei University;   Fujian Cancer Hospital;   Tengzhou Central People's Hospital;   The First Affiliated Hospital of Zhengzhou University;   The Affiliated Hospital of Inner Mongolia Medical University;   Sichuan Cancer Hospital and Research Institute
    Recruiting

  • Conditions:   Venous Thromboembolism;   Esophagus Cancer;   Bleeding;   Chemotherapy Effect
    Intervention:   Other: Venous thromboembolic event, arterial thromboembolic event, bleeding events
    Sponsor:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
    Recruiting

  • Conditions:   Esophageal Adenocarcinoma;   Esophagus SCC;   Cholangiocarcinoma;   Urothelial/Bladder Cancer, Nos;   Endometrial Cancer
    Intervention:   Drug: Abemaciclib
    Sponsors:   Jules Bordet Institute;   Eli Lilly and Company
    Recruiting

  • Conditions:   Circulatory; Change;   Microcirculation
    Intervention:  
    Sponsor:   Oslo University Hospital
    Recruiting

  • Conditions:   GORD;   Oesophageal Cancer;   Oesophageal Reflux;   Gastric Cancer;   Gastro Esophageal Reflux;   Oesophageal Carcinoma;   Barrett Esophagus;   Esophagitis
    Intervention:   Diagnostic Test: No intervention but patients are undergoing an upper GI endoscopy and biopsies for clinical purposes
    Sponsor:   Imperial College London
    Recruiting

  • Conditions:   Cancer;   Esophagus Squamous Cell Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Anal Canal Squamous Cell Carcinoma;   Metastatic Cancer
    Intervention:  
    Sponsor:   University Health Network, Toronto
    Recruiting

  • Conditions:   Esophageal Neoplasms;   Cancer of Esophagus;   Cancer of the Esophagus;   Esophageal Cancer;   Esophagus Cancer;   Neoplasm, Esophageal;   Esophagectomy
    Intervention:   Other: Mayo Clinic Conduit Report Card Questionnaires
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Esophageal Disease
    Intervention:  
    Sponsors:   University Hospital, Lille;   French Eso-Gastric Tumors Working Group;   National Cancer Institute, France
    Recruiting

  • Conditions:   Cancer;   Cancer of Pancreas;   Cancer of Liver;   Cancer of Esophagus;   Cancer of Stomach;   Cancer, Metastatic
    Intervention:  
    Sponsor:   Rigshospitalet, Denmark
    Recruiting

  • Conditions:   Esophageal Cancer;   GastroEsophageal Cancer
    Interventions:   Drug: APX005M;   Radiation: Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Procedure: Surgical resection of tumor
    Sponsors:   University of California, San Francisco;   Apexigen, Inc.
    Recruiting

  • Conditions:   Positive-Pressure Respiration/Methods;   Esophagus/Physiopathology;   Pleura/Physiopathology;   Gynecologic Surgical Procedures;   Laparoscopy;   Humans;   Female
    Intervention:   Procedure: PEEP setting based on esophageal pressure measured
    Sponsor:   Mahidol University
    Recruiting

  • Conditions:   B-cell Acute Lymphoblastic Leukemia;   Lymphoma;   Myeloid Leukemia;   Multiple Myeloma;   Hepatoma;   Gastric Cancer;   Pancreatic Cancer;   Mesothelioma;   Colorectal Cancer;   Esophagus Cancer;   Lung Cancer;   Glioma;   Melanoma;   Synovial Sarcoma;   Ovarian Cancer;   Renal Carcinoma
    Intervention:   Biological: CAR-T cell immunotherapy
    Sponsors:   Shenzhen BinDeBio Ltd.;   The First Affiliated Hospital of Zhengzhou University
    Recruiting

  • Conditions:   Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer;   Esophagus Cancer;   Lung Cancer, Nonsmall Cell;   Squamous Cell Carcinoma of the Head and Neck
    Intervention:   Drug: Tisotumab Vedotin
    Sponsor:   Genmab
    Recruiting

  • Conditions:   Head and Neck Cancer;   Head and Neck Squamous Cell Carcinoma;   Head and Neck Carcinoma;   Head and Neck Cancer Stage III;   Head and Neck Cancer Stage IV;   Head and Neck Cancer Metastatic;   Cancer;   Cancer of Esophagus;   Cancer, Metastatic;   Cancer of Head and Neck;   Cancer of Mouth;   Cancer of Neck
    Interventions:   Drug: Pembrolizumab;   Drug: Tadalafil
    Sponsor:   University of California, San Diego
    Not yet recruiting

  • Conditions:   Cancer, All Types;   Cancer of Liver;   Cancer of Stomach;   Cancer of Head and Neck;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Colon;   Cancer Skin;   Cancer of Cervix;   Cancer, Metastatic;   Cancer of Larynx;   Cancer of Neck;   Cancer of Lung;   Cancer of Brain and Nervous System;   Cancer of Vulva, Disseminated;   Cancer of Pancreas;   Sarcoma;   GIST;   Small-cell Lung Cancer;   Adenocarcinoma Lung;   Cancer of Prostate;   Cancer, Advanced;   Adrenal Cancer;   Testicular Cancer;   Uterine Cancer;   Bronchoalveolar Cell Lung Cancer;   Cancer Unknown Primary;   Glioblastoma Multiforme;   Oligodendroglioma;   Breast Cancer;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Squamous Cell Carcinoma;   Transitional Cell Carcinoma;   Cancer, Other;   Cancer, Anal;   Melanoma;   Cancer, Bile Duct;   Cancer, Bladder;   Cancer Cords Vocal;   Cancers Cell Neuroendocrine;   Cancer Differentiated Poorly;   Cancer, Anaplastic Thyroid
    Intervention:  
    Sponsors:   SpeciCare;   Dana-Farber Cancer Institute;   Kalispell Regional Medical Center;   Georgia Institute of Technology;   Ontario Institute for Cancer Research;   SEngine Precision Medicine;   Helomics
    Recruiting

  • Conditions:   Cancer, Metastatic;   Cancer;   Cancer of Pancreas;   Cancer of Liver;   Cancer of Stomach;   Cancer Liver;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Cervix;   Cancer of Colon;   Cancer of Larynx;   Cancer, Lung;   Cancer, Breast;   Cancer, Advanced;   Cancer Prostate;   Cancer of Neck;   Cancer of Skin;   Neuroendocrine Tumors;   Carcinoma;   Mismatch Repair Deficiency;   BRCA Gene Rearrangement;   Non Hodgkin Lymphoma;   Leukemia;   Non Small Cell Lung Cancer;   Cholangiocarcinoma;   Glioblastoma;   Central Nervous System Tumor;   Melanoma;   Urothelial Carcinoma;   Bladder Cancer;   Ovarian Cancer;   Endometrial Cancer;   Testicular Cancer;   Breast Cancer
    Intervention:   Other: Clinical Trial Matching
    Sponsor:   Massive Bio, Inc.
    Recruiting

  • Conditions:   Cancer of Unknown Origin;   Cancer Refractory;   Cancer of Stomach;   Cancer Head Neck;   Cancer of Skin;   Cancer, Lung;   Cancer Colorectal;   Cancer of Esophagus;   Cancer, Bladder;   Cancer, Uterus;   Cancer Cervix;   Cancer Liver;   Cancer, Kidney;   Cancer, Breast;   Hematologic Neoplasms
    Intervention:   Other: Genomic testing
    Sponsors:   Arbeitsgemeinschaft medikamentoese Tumortherapie;   Roche Pharma AG
    Recruiting

  • Conditions:   Radiation Therapy;   Cancer;   Cancer of Anus;   Cancer of Bladder;   Cancer of Cervix;   Cancer of Colon;   Cancer of Rectum;   Cancer of Esophagus;   Cancer of Gallbladder;   Cancer of Liver;   Cancer of Ovary;   Cancer of Pancreas;   Cancer of Prostate;   Cancer of Kidney and Renal Pelvis;   Cancer of Stomach;   Cancer of Testis;   Cancer of Uterus;   Cancer of Uterus and Cervix;   Cancer of Kidney
    Intervention:  
    Sponsors:   DxTerity Diagnostics;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Anatomic Stage II Breast Cancer;   Anatomic Stage IIA Breast Cancer;   Anatomic Stage IIB Breast Cancer;   Anatomic Stage III Breast Cancer;   Anatomic Stage IIIA Breast Cancer;   Anatomic Stage IIIB Breast Cancer;   Anatomic Stage IIIC Breast Cancer;   Clinical Stage II Esophageal Adenocarcinoma;   Clinical Stage II Esophageal Squamous Cell Carcinoma;   Clinical Stage II Gastric Cancer;   Clinical Stage II Gastroesophageal Junction Adenocarcinoma;   Clinical Stage IIA Esophageal Adenocarcinoma;   Clinical Stage IIA Gastric Cancer;   Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma;   Clinical Stage IIB Esophageal Adenocarcinoma;   Clinical Stage IIB Gastric Cancer;   Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma;   Clinical Stage III Esophageal Adenocarcinoma;   Clinical Stage III Esophageal Squamous Cell Carcinoma;   Clinical Stage III Gastric Cancer;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma;   Distal Esophagus Squamous Cell Carcinoma;   Esophageal Carcinoma;   Estrogen Receptor Negative;   HER2/Neu Negative;   Limited Stage Small Cell Lung Carcinoma;   Malignant Solid Neoplasm;   Non-Small Cell Lung Carcinoma;   Pancreatic Adenocarcinoma;   Pathologic Stage II Esophageal Adenocarcinoma;   Pathologic Stage II Esophageal Squamous Cell Carcinoma;   Pathologic Stage II Gastric Cancer;   Pathologic Stage II Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIA Esophageal Adenocarcinoma;   Pathologic Stage IIA Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIA Gastric Cancer;   Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIB Esophageal Adenocarcinoma;   Pathologic Stage IIB Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIB Gastric Cancer;   Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage III Esophageal Adenocarcinoma;   Pathologic Stage III Esophageal Squamous Cell Carcinoma;   Pathologic Stage III Gastric Cancer;   Pathologic Stage III Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIIA Esophageal Adenocarcinoma;   Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIIA Gastric Cancer;   Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIIB Esophageal Adenocarcinoma;   Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIIB Gastric Cancer;   Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIIC Gastric Cancer;   Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage II Gastric Cancer;   Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma;   Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage III Gastric Cancer;   Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma;   Progesterone Receptor Negative;   Prognostic Stage II Breast Cancer;   Prognostic Stage IIA Breast Cancer;   Prognostic Stage IIB Breast Cancer;   Prognostic Stage III Breast Cancer;   Prognostic Stage IIIA Breast Cancer;   Prognostic Stage IIIB Breast Cancer;   Prognostic Stage IIIC Breast Cancer;   Stage I Pancreatic Cancer;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage II Lung Cancer;   Stage II Pancreatic Cancer;   Stage IIA Lung Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Lung Cancer;   Stage IIB Pancreatic Cancer;   Stage III Lung Cancer;   Stage IIIA Lung Cancer;   Stage IIIB Lung Cancer;   Stage IIIC Lung Cancer;   Triple-Negative Breast Carcinoma
    Interventions:   Drug: Ifetroban Sodium;   Other: Placebo
    Sponsors:   Vanderbilt-Ingram Cancer Center;   Cumberland Pharmaceuticals
    Recruiting

  • Conditions:   Clinical Stage I Esophageal Adenocarcinoma AJCC v8;   Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage II Esophageal Adenocarcinoma AJCC v8;   Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage III Esophageal Adenocarcinoma AJCC v8;   Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage I Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage II Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage III Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Thoracic Esophagus Squamous Cell Carcinoma
    Interventions:   Drug: Carboplatin;   Procedure: Esophagectomy;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Paclitaxel;   Radiation: Proton Beam Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   NRG Oncology;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   a. Colorectal Cancer;   b. High Grade Serous Ovarian Cancer;   c. Non Small-cell Lung Cancer (Squamous Cell Variant);   d. Squamous Carcinoma of the Oesophagus;   e. Squamous Carcinoma of the Head and Neck (HPV Negative);   f. Urothelial Cancer;   g. Breast Cancer (Triple Negative Type);   h. Pancreatic Cancer
    Intervention:   Drug: LY3143921 hydrate
    Sponsor:   Cancer Research UK
    Recruiting

  • Conditions:   Gastroesophageal Reflux;   GERD
    Interventions:   Procedure: Confocal endomicroscopy;   Procedure: Mucosal impedance;   Procedure: Research biopsies;   Procedure: Bravo ambulatory pH monitor
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Advanced Esophageal Cancer
    Interventions:   Biological: Anti-MUC1 CAR-T cells;   Biological: PD-1 knockout Engineered T cells;   Combination Product: CAR-T combined with PD-1 Knockout T cells
    Sponsors:   The First Affiliated Hospital of Guangdong Pharmaceutical University;   Guangzhou Anjie Biomedical Technology Co., Ltd.
    Recruiting

  • Conditions:   Esophageal Stricture;   Eosinophilic Esophagitis;   Zenkers Diverticulum;   Schatzki Ring
    Intervention:   Device: EndoFLIP
    Sponsor:   University of Pennsylvania
    Recruiting

  • Conditions:   Esophageal Cancer;   Gastric Cancer
    Intervention:   Drug: Afatinib and Paclitaxel
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Boehringer Ingelheim;   University of Southern California;   Dana-Farber Cancer Institute;   United States Department of Defense
    Recruiting

  • Condition:   Digestive System Neoplasm
    Intervention:   Other: Biological collection
    Sponsor:   Institut du Cancer de Montpellier - Val d'Aurelle
    Recruiting

  • Condition:   Esophageal Squamous Cell Carcinoma (ESCC)
    Interventions:   Drug: BGB-A317;   Drug: Paclitaxel, or Docetaxel, or Irinotecan
    Sponsor:   BeiGene
    Recruiting


PaidClinicalTrials.orgPaidClinicalTrials.org